Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 16/10/2019
SIETES contiene 92824 citas

 
 
 1 a 15 de 15 
Presentar resultados
Seleccionar todas
1. Cita con resumen
Buckley NA, Dawson AH, Isbister GK. Serotonin syndrome. BMJ 2014;348:g1626. [Ref.ID 97343]
2.Tiene citas relacionadas Cita con resumen
Kuehn BM. Serotonin syndrome update. JAMA 2011;306:2661. [Ref.ID 91993]
4. Cita con resumen
Youngster I, Arcavi L, Schechmaster R, Akayzen Y, Popliski H, Shimonov J, Beig S, Berkovitch M. Medications and glucose-6-phosphate dehydrogenase deficiency: an evidence-based review. Drug Saf 2010;33:713-26. [Ref.ID 89267]
5. Cita con resumen
Walter-Sack I, Rengelshausen J, Oberwittler H, Burhenne J, Mueller O, Meissner P, Mikus G. High absolute bioavailability of methylene blue given as an aqueous oral formulation. Eur J Clin Pharmacol 2009;65:179-89. [Ref.ID 85238]
6.Tiene citas relacionadas Cita con resumen
Jones AL. Adverse drug reactions to poison antidotes: Part 2. Adv Drug React Bull 2004;228:1-4. [Ref.ID 72325]
7.Tiene citas relacionadas Cita con resumen
Jones AL. Adverse drug reactions to poison antidotes: Part 1. Adv Drug React Bull 2004;228:1-4. [Ref.ID 72322]
8. Cita con resumen
Kaushik P, Zuckerman SJ, Campo NJ, Banda VR, Hayes SD, Kaushik R. Celecoxib-induced methemoglobinemia. Ann Pharmacother 2004;38:1635-8. [Ref.ID 71560]
9. Cita con resumen
Peter C, Hongwan D, Küpfer A, Lauterburg BH. Pharmacokinetics and organ distribution of intravenous and oral methylene blue. Eur J Clin Pharmacol 2000;56:247-50. [Ref.ID 51511]
10. Cita con resumen
Zanfi D. Deficit di glucosio-6-fosfato deidrogenasi: quali farmaci evitare?. Informazioni sui Farmaci 1999;23:139-40. [Ref.ID 48251]
11.
Bowden CA, Krenzelok EP. Clinical applications of commonly used contemporary antidotes: a US perspective. Drug Saf 1997;16:9-47. [Ref.ID 30350]
12.
Mehta AB. Glucose-6-phosphate dehydrogenase deficiency. Prescr J 1994;34:178-82. [Ref.ID 22924]
13. Cita con resumen
Küpfer A, Aeschlimann C, Wermuth B, Cerny T. Prophylaxis and reversal of ifosfamide encephalopathy with methylene-blue. Lancet 1994;343:763-4. [Ref.ID 21550]
14. Cita con resumen
Addis A. Deficit di G6PD e farmaci. Ricerca e Pratica 1991;7:167-9. [Ref.ID 16795]
15. Cita con resumen
Disanto AR, Wagner JG. Pharmacokinetics of highly ionized drugs. I: Methylene blue -Whole blood, urine and tissue assays. J Pharm Sci 1972;61:598-602. [Ref.ID 66]
Seleccionar todas
 
 1 a 15 de 15